Splunk Licenses

The Food and Drug Administration is forecasting the acquisition of Splunk licenses to implement a comprehensive end-to-end solution for monitoring and analyzing end user activities across both on-premises and cloud-based system components. This initiative aims to bolster enterprise-wide system health assessments, enhance auditing capabilities, and improve usage analytics while enabling real-time detection of cyber security threats. The solution is intended to provide continuous visibility into system interactions, strengthening the agency’s ability to identify anomalies and respond to potential attacks promptly. The contract is classified under NAICS code 541519, indicating it pertains to other computer-related services, and was posted on May 25, 2026, as a forecast opportunity. The point of contact for program-related inquiries is the Cder Acquisition Liaison at cderacquisitions@fda.hhs.gov, while the contracting officer details are still pending. No specific place of performance or set-aside information is provided, and the procurement is currently in the forecasting phase, with no solicitation number assigned yet. Stakeholders are encouraged to monitor the opportunity through the provided federal business portal for updates as the procurement progresses.